본문 바로가기
KERD
논문KCI 등재

Biology of Cholangiocytes: From Bench to Bedside

Kyo-Sang Yoo|Ho Soon Choi|Woo Taek Lim
거트앤리버 소화기연관학회협의회|2016.09|Gut and Liver|제10권 제5호|pp. 687-698

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

BiologyTransportReceptorsCholangiocyteCholangiopathy

초록

Cholangiocytes, the lining epithelial cells in bile ducts, are an important subset of liver cells. They are activated by endogenous and exogenous stimuli and are involved in the modification of bile volume and composition. They are also involved in damaging and repairing the liver. Cholangiocytes have many functions including bile production. They are also involved in transport processes that regulate the volume and composition of bile. Cholangiocytes undergo proliferation and cell death under a variety of conditions. Cholangiocytes have functional and morphological heterogenecity. The immunobiology of cholangiocytes is important, particularly for understanding biliary disease. Secretion of different proinflammatory mediators, cytokines, and chemokines suggests the major role that cholangiocytes play in inflammatory reactions. Furthermore, paracrine secretion of growth factors and peptides mediates extensive cross-talk with other liver cells, including hepatocytes, stellate cells, stem cells, subepithelial myofibroblasts, endothelial cells, and inflammatory cells. Cholangiopathy refers to a category of chronic liver diseases whose primary disease target is the cholangiocyte. Cholangiopathy usually results in end-stage liver disease requiring liver transplant. We summarize the biology of cholangiocytes and redefine the concept of cholangiopathy. We also discuss the recent progress that has been made in understanding the pathogenesis of cholangiopathy and how such progress has influenced therapy.

Abstract

Cholangiocytes, the lining epithelial cells in bile ducts, are an important subset of liver cells. They are activated by endogenous and exogenous stimuli and are involved in the modification of bile volume and composition. They are also involved in damaging and repairing the liver. Cholangiocytes have many functions including bile production. They are also involved in transport processes that regulate the volume and composition of bile. Cholangiocytes undergo proliferation and cell death under a variety of conditions. Cholangiocytes have functional and morphological heterogenecity. The immunobiology of cholangiocytes is important, particularly for understanding biliary disease. Secretion of different proinflammatory mediators, cytokines, and chemokines suggests the major role that cholangiocytes play in inflammatory reactions. Furthermore, paracrine secretion of growth factors and peptides mediates extensive cross-talk with other liver cells, including hepatocytes, stellate cells, stem cells, subepithelial myofibroblasts, endothelial cells, and inflammatory cells. Cholangiopathy refers to a category of chronic liver diseases whose primary disease target is the cholangiocyte. Cholangiopathy usually results in end-stage liver disease requiring liver transplant. We summarize the biology of cholangiocytes and redefine the concept of cholangiopathy. We also discuss the recent progress that has been made in understanding the pathogenesis of cholangiopathy and how such progress has influenced therapy.

참고문헌 (102)

  1. Alpini G, "The pathobiology of biliary epithelia", Hepatology, 35, pp.1256~1268 (2002)
  2. Strazzabosco M, "Pathophysiology of the intrahepatic biliary epithelium", J Gastroenterol Hepatol, 15, pp.244~253 (2000)
  3. Roberts SK, "The pathobiology of biliary epithelia", Gastroenterology, 112, pp.269~279 (1997)
  4. Tietz PS, "Cholangiocyte biology", Curr Opin Gastroenterol, 22, pp.279~287 (2006)
  5. Strazzabosco M, "Pathophysiology of cholangiopathies", J Clin Gastroenterol, 39(4 Suppl 2), pp.S90~S102 (2005)
  6. Lazaridis KN, "The cholangiopathies", Mayo Clin Proc, 90, pp.791~800 (2015)
  7. Lazaridis KN, "The cholangiopathies:disorders of biliary epithelia", Gastroenterology, 127, pp.1565~1577 (2004)
  8. Bogert PT, "Cholangiocyte biology", Curr Opin Gastroenterol, 23, pp.299~305 (2007)
  9. Alvaro D, "Proliferating cholangiocytes:a neuroendocrine compartment in the diseased liver", Gastroenterology, 132, pp.415~431 (2007)
  10. Marzioni M, "Functional heterogeneity of cholangiocytes", Semin Liver Dis, 22, pp.227~240 (2002)
  11. Cardinale V, "Multipotent stem", progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets, 2011, pp.54, 2159~2172
  12. Carpino G, "Biliary tree stem", progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages, 2012, pp.220, 186~199
  13. Desmet VJ, "Vanishing bile duct disorders", Prog Liver Dis, 10, pp.89~121 (1992)
  14. Sirica AE, "Biology of biliary epithelial cells", Prog Liver Dis, 10, pp.63~87 (1992)
  15. Onori P, "Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions", Ital J Anat Embryol, 106(2 Suppl 1), pp.371~378 (2001)
  16. Nakanuma Y, "Pathology and pathogenesis of intrahepatic bile duct loss", J Hepatobiliary Pancreat Surg, 8, pp.303~315 (2001)
  17. Liu Z, "Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130signaling in the ductular reaction", Liver, 20, pp.114~124 (2000)
  18. Reynoso-Paz S, "Vanishing bile duct syndromes: considerations of the immunobiology of autoimmune biliary diseases", Isr Med Assoc J, 1, pp.37~44 (1999)
  19. O’Hara SP, "The dynamic biliary epithelia: molecules, pathways, and disease", J Hepatol, 58, pp.575~582 (2013)
  20. Desmet VJ, "Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered", Virchows Arch, 458, pp.251~259 (2011)
  21. Tietz PS, "Experimental models to study cholangiocyte biology", World J Gastroenterol, 8, pp.1~4 (2002)
  22. Masyuk TV, "Quantitative assessment of the rat intrahepatic biliary system by three-dimensional reconstruction", Am J Pathol, 158, pp.2079~2088 (2001)
  23. Khaoustov VI, "Induction of three-dimensional assembly of human liver cells by simulated microgravity", In Vitro Cell Dev Biol Anim, 35, pp.501~509 (1999)
  24. Joplin R, "Isolation and culture of biliary epithelial cells", Gut, 35, pp.875~878 (1994)
  25. Splinter PL, "AQP4 transfected into mouse cholangiocytes promotes water transport in biliary epithelia", Hepatology, 39, pp.109~116 (2004)
  26. Shibao K, "Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis", Gastroenterology, 125, pp.1175~1187 (2003)
  27. Baiocchi L, "Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats", J Hepatol, 38, pp.136~147 (2003)
  28. Feranchak AP, "Cholangiocyte biology and cystic fibrosis liver disease", Semin Liver Dis, 21, pp.471~488 (2001)
  29. Feranchak AP, "The lipid products of phosphoinositide 3-kinase contribute to regulation of cholangiocyte ATP and chloride transport", J Biol Chem, 274, pp.30979~30986 (1999)
  30. Melero S, "Defective regulation of cholangiocyte Cl-", HCO3(-) and Na+, Hepatology, pp.2002, 35[DOI]
  31. Feranchak AP, "Adenosine triphosphate release and purinergic regulation of cholangiocyte transport", Semin Liver Dis, 22, pp.251~262 (2002)
  32. Roman RM, "Endogenous ATP release regulates Cl- secretion in cultured human and rat biliary epithelial cells", Am J Physiol, 276(6 Pt 1), pp.G1391~G1400 (1999)
  33. Zsembery A, "Purinergic regulation of acid", base transport in human and rat biliary epithelial cell lines, 1998, pp.28, 914~920
  34. Strazzabosco M, "Na(+)-dependent and -independent Cl-", HCO-3 exchange mediate cellular HCO3-transport in cultured human intrahepatic bile duct cells, 1997, pp.25, 976~985
  35. Strazzabosco M., "Transport systems in cholangiocytes: their role in bile formation and cholestasis", Yale J Biol Med, 70, pp.427~434 (1997)
  36. LeSage GD, "Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver", Hepatology, 29, pp.307~319 (1999)
  37. Alpini G, "Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation", Am J Physiol, 274(4 Pt 1), pp.G767~G775 (1998)
  38. Alpini G, "Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver", Gastroenterology, 110, pp.1636~1643 (1996)
  39. Alvaro D, "Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats", Gastroenterology, 119, pp.1681~1691 (2000)
  40. Park J, "Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44", p42 mitogen-activated protein kinase, 1999, pp.29, 1037~1043
  41. Chen XM, "Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism", Hepatology, 28, pp.906~913 (1998)
  42. Celli A, "Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma", Semin Liver Dis, 18, pp.177~185 (1998)
  43. Syal G, "Advances in cholangiocyte immunobiology", Am J Physiol Gastrointest Liver Physiol, 303, pp.G1077~G1086 (2012)
  44. Fava G, "The immunophysiology of biliary epithelium", Semin Liver Dis, 25, pp.251~264 (2005)
  45. Chuang YH, "The immunopathology of human biliary cell epithelium", Semin Immunopathol, 31, pp.323~331 (2009)
  46. Reynoso-Paz S, "Gershwin ME. The immunobiology of bile and biliary epithelium", Hepatology, 30, pp.351~357 (1999)
  47. Ueno Y, "Development and characterization of a rodent model of immunemediated cholangitis", Proc Natl Acad Sci U S A, 93, pp.216~220 (1996)
  48. LaRusso NF, "Morphology, physiology, and biochemistry of biliary epithelia", Toxicol Pathol, 24, pp.84~89 (1996)
  49. Galperin C, "Immunopathology of primary biliary cirrhosis", Baillieres Clin Gastroenterol, 10, pp.461~481 (1996)
  50. Savard CE, "Expression of cytokine and chemokine mRNA and secretion of tumor necrosis factor-alpha by gallbladder epithelial cells: response to bacterial lipopolysaccharides", BMC Gastroenterol, 2, pp.23~ (2002)
  51. Choi HS, "Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts", J Surg Res, 141, pp.183~191 (2007)
  52. 최호순, "담낭상피세포에서 옥시스테롤(3,5-cholestadien-7-one, 5-β-cholestan-3-one, 5,24-cholestadien-3β-OL)의 세포독성과 세포자사멸", 대한소화기학회지, 44(6), pp.328~336 (2004), 대한소화기학회
  53. Yoon JH, "ATP-binding cassette sterol transporters are differentially expressed in normal and diseased human gallbladder", Dig Dis Sci, 58, pp.431~439 (2013)
  54. Tauscher A, "ABCG5 and ABCG8 are expressed in gallbladder epithelial cells", Biochem Biophys Res Commun, 307, pp.1021~1028 (2003)
  55. Biochem J, "Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway", Biochem J, 364(2), pp.475~484 (2002)
  56. Jacyna MR, "Characteristics of cholesterol absorption by human gall bladder: relevance to cholesterolosis", J Clin Pathol, 40, pp.524~529 (1987)
  57. Neiderhiser DH, "Absorption of cholesterol by the gallbladder", J Lipid Res, 17, pp.117~124 (1976)
  58. Angelin B, "Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL", Atheroscler Suppl, 3, pp.23~30 (2002)
  59. Movva R, "Laboratory assessment of HDL heterogeneity and function", Clin Chem, 54, pp.788~800 (2008)
  60. Yancey PG, "Importance of different pathways of cellular cholesterol efflux", Arterioscler Thromb Vasc Biol, 23, pp.712~719 (2003)
  61. Rothblat GH, "Cell cholesterol efflux: integration of old and new observations provides new insights", J Lipid Res, 40, pp.781~796 (1999)
  62. Ji Y, "Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux", J Biol Chem, 272, pp.20982~20985 (1997)
  63. Lee JY, "ATP-binding cassette transporter AI and its role in HDL formation", Curr Opin Lipidol, 16, pp.19~25 (2005)
  64. Wittenburg H, "Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8", J Clin Invest, 110, pp.605~609 (2002)
  65. Yu L, "Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol", J Clin Invest, 110, pp.671~680 (2002)
  66. Lee J, "Introduction of a model for study of polarized cholesterol and phospholipid efflux in gallbladder epithelial cells", Korean J Gastroenterol, 39, pp.216~225 (2002)
  67. Lee J, "Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E", Am J Physiol Gastrointest Liver Physiol, 285, pp.G630~G641 (2003)
  68. Lee J, "Reverse cholesterol transport in cultured gallbladder epithelial cells", Korean J Gastroenterol, 43, pp.145~152 (2004)
  69. Choi HS, "ABCA1 expression of human gallbladder tissue in various gallbladder diseases", Korean J Gastroenterol, 41, pp.599A~ (2003)
  70. Choi HS, "The biology of the cholangiocytes", Hanyang Med Rev, 27, pp.4~12 (2007)
  71. Lee J, "Transporters and nuclear hormone receptors associated with cholesterol metabolism in gallbladder epithelial cells", Hanyang Med Rev, 27, pp.20~28 (2007)
  72. Lee J, "The effect of PPARalpha and PPARgamma ligands on inflammation and ABCA1 expression in cultured gallbladder epithelial cells", Dig Dis Sci, 53, pp.1707~1715 (2008)
  73. Lee J, "HMG-CoA reductase inhibitors (statins) activate expression of PPARalpha", PPARgamma and ABCA1 in cultured gallbladder epithelial cells, 2010, pp.55, 292~299
  74. Marzioni M, "Clinical implications of novel aspects of biliary pathophysiology", Dig Liver Dis, 42, pp.238~244 (2010)
  75. Maroni L, "Functional and structural features of cholangiocytes in health and disease", Cell Mol Gastroenterol Hepatol, 1, pp.368~380 (2015)
  76. Pellicciari R, "6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity", J Med Chem, 45, pp.3569~3572 (2002)
  77. Sinal CJ, "Targeted disruption of the nuclear receptor FXR", BAR impairs bile acid and lipid homeostasis, 2000, pp.102, 731~744
  78. Cohen BI, "Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit", Gastroenterology, 91, pp.189~197 (1986)
  79. Hohenester S, "A biliary HCO3-umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes", Hepatology, 55, pp.173~183 (2012)
  80. Iwai M, "Alteration in sympathetic nerve activity during liver regeneration in rats after partial hepatectomy", J Auton Nerv Syst, 41, pp.209~214 (1992)
  81. LeSage GD, "Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP", Hepatology, 40, pp.1116~1127 (2004)
  82. Francis H, "The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile ductligated rats", Am J Physiol Cell Physiol, 293, pp.C1252~C1262 (2007)
  83. Marzioni M, "Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver", Liver Int, 27, pp.558~568 (2007)
  84. Glaser S, "Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt", Am J Physiol Gastrointest Liver Physiol, 290, pp.G813~G826 (2006)
  85. Marzioni M, "Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis", Gastroenterology, 130, pp.1831~1847 (2006)
  86. Alvaro D, "The intrahepatic biliary epithelium is a target of the growth hormone", insulin-like growth factor 1 axis, 2005, pp.43, 875~883
  87. Gaudio E, "Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism", Gastroenterology, 130, pp.1270~1282 (2006)
  88. Gaudio E, "Administration of r-VEGFA prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats", Am J Physiol Gastrointest Liver Physiol, 291, pp.G307~G317 (2006)
  89. Drucker DJ, "Biological actions and therapeutic potential of the glucagon-like peptides", Gastroenterology, 122, pp.531~544 (2002)
  90. Marzioni M, "Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis", Gastroenterology, 133, pp.244~255 (2007)
  91. Hanada S, "Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes", Liver Int, 23, pp.3~11 (2003)
  92. Spirlì C, "Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes", Gastroenterology, 124, pp.737~753 (2003)
  93. Eksteen B, "Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10", J Immunol, 177, pp.593~603 (2006)
  94. Karrar A, "Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis", Gastroenterology, 132, pp.1504~1514 (2007)
  95. Salas JT, "Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis", Gastroenterology, 134, pp.1482~1493 (2008)
  96. Moritoki Y, "B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice", Hepatology, 50, pp.1893~1903 (2009)
  97. Tsuda M, "Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid", Hepatology, 55, pp.512~521 (2012)
  98. Lleo A, "Towards common denominators in primary biliary cirrhosis: the role of IL-12", J Hepatol, 56, pp.731~733 (2012)
  99. Hirschfield GM, "Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants", N Engl J Med, 360, pp.2544~2555 (2009)
  100. Eaton JE, "Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management", Gastroenterology, 145, pp.521~536 (2013)
  101. Liaskou E, "Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity", Hepatology, 53, pp.661~672 (2011)
  102. Moon HJ, "Human lysyl oxidase-like 2", Bioorg Chem, 57, pp.231~241 (2014)

관련 논문AI추천

The Crucial Role of Cholangiocytes in Cholangiopathies박선미거트앤리버 소화기연관학회협의회 · Gut and Liver2012 · 제6권 제3호Cellular Plasticity in Gut and Liver RegenerationKim Minwook, Kim You Sun, Ko Sungjin, Park Yoojeong거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제6호Bile Acid Transporters Are Expressed and Heterogeneously Distributed in Rat Bile DuctsFu-zhou Tian, Ke Xiang, Li-jun Tang, Lin Cui, Long Cheng, Tao Wang, Zhu-lin Luo거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제5호폐쇄성 담관질환에서 관찰되는 담소관증식의 기원에 관한 면역조직화학적 연구금윤섭, 박관규, 박재복, 성현정, 안병철, 이재태대한병리학회 · Journal of Pathology and Translational Medicine2009 · 제43권 제2호A decade of liver organoids: Advances in disease modelingChun-Fang Yang, Jian-Ying Sheng, Junjun Ding, Yue Liu, Yun-Shen Chan대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Liver organoids: Current advances and future applications for hepatologyDongho Choi, Meritxell Huch, Michael Adisasmita, Michael Girma Mamo, Minseok Kang, Yohan Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호

이 간행물의 다른 논문 (28건)

How Can We Propagate the National Endoscopy Quality Improvement Program and Improve the Quality of Endoscopic Screening?Dong-Hoon Yangpp. 657-658Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages정대영pp. 659-660Nonzero Risk of Hepatocellular Carcinoma Even after Sustained Virological ResponseHyun Woong Leepp. 661-662The Clinical Utility of MicroRNA as a Prognostic Biomarker of Pancreatobiliary CancersKyu Taek Leepp. 663-664The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic CancerPaolo Boffetta, Sunil Amin, Aimee L. Lucaspp. 665-671
원문 보기